U.S. Markets close in 5 hrs 51 mins

Singapore eDevelopment Limited (40V.SI)

SES - SES Delayed Price. Currency in SGD
Add to watchlist
0.0870-0.0030 (-3.33%)
At close: 5:04PM SGT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0900
Open0.0910
Bid0.0870 x 0
Ask0.0880 x 0
Day's Range0.0860 - 0.0910
52 Week Range0.0260 - 0.1380
Volume11,653,900
Avg. Volume54,691,216
Market Cap134.807M
Beta (5Y Monthly)1.38
PE Ratio (TTM)N/A
EPS (TTM)-0.0120
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    DSS Announces Update On the Acquisition of Impact Biomedical

    ROCHESTER, N.Y., July 15, 2020 -- Document Security Systems, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating businesses focusing on brand.

  • GlobeNewswire

    Update on Acquisition of Impact Biomedical, Inc.

    Document Security Systems, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a leader in anti-counterfeit, authentication and diversion protection technologies, announces the completion of the required independent valuation, allowing the company to proceed with the acquisition of the stock of Impact BioMedical, Inc. (“Impact BioMedical”) through a share exchange agreement as outlined in the term sheet announced on March 12, 2020  (the “Term Sheet”) among DSS, DSS BioHealth Security, Inc., a wholly-owned direct subsidiary of DSS, Impact BioMedical and Global BioMedical Pte. Ltd. (“Global BioMedical”), which owns all of the stock of Impact BioMedical. Impact BioMedical’s ownership of a suite of antiviral and medical technologies has been valued at $382 million.

  • GlobeNewswire

    Todos Medical Signs Binding Term Sheet with HWH World for Network Marketing of Blood Tests for the Early Detection of Breast Cancer

    Todos Medical Ltd. (TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, today announced it has entered into a binding term sheet with HWH World Pte Ltd. (“HWH World”), a wholly-owned subsidiary of Singapore eDevelopment (40V.SI) for the grant of exclusive marketing rights for Todos Medical’s TM-B1 and TM-B2 tests to HWH World’s network of members in Singapore, Malaysia, the Philippines, Vietnam, Thailand, Indonesia, South Korea, Hong Kong, China, the United States and Canada. HWH World is a marketing firm that focuses on health and wellness.